RVL Pharmaceuticals Market Cap

RVL Pharmaceuticals has a market cap or net worth of $111.00 as of August 15, 2025. Its market cap has decreased by -100.00% in one year.

Market Cap

111.00

Enterprise Value

n/a

Revenue

36.92M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since October 18, 2018, RVL Pharmaceuticals's market cap has decreased from 419.90M to 111.00, a decrease of -100.00%. That is a compound annual growth rate of -89.11%.

Market Cap History

Date	Market Cap	% Change
Aug 15, 2025	111.00	-
Dec 31, 2024	111.00	-99.97%
Dec 29, 2023	334.22K	-99.70%
Dec 30, 2022	111.05M	23.46%
Dec 31, 2021	89.95M	-65.11%
Dec 31, 2020	257.85M	-28.96%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Veradigm	798.20M
Tian'an Technology Group	628.15M
Glass House Brands	598.01M
Elite Pharmaceuticals	567.50M
Nika Pharmaceuticals	360.27M
Northwest Biotherapeutics	349.08M
American Oncology Network	337.45M
CytoDyn	325.38M

Market Cap Rankings